 |
市場調查報告書
商品編碼
1986225
全球獸藥契約製造和研究市場（至 2031 年）：按服務（藥物發現研究、原料藥開發、法規遵循、諮詢、包裝和標籤）、產品（原料藥、灌裝、醫療設備）和動物類型（伴侶動物、牲畜）分類Veterinary Contract Manufacturing & Research Market by Service (Discovery, API Development, Regulatory Affairs, Consulting, Packaging & Labeling), Product (API, Fill-Finish, Medical Devices), Animal Type (Companion, Livestock) - Global Forecast to 2031 |
||||||
價格
預計動物保健領域契約製造和研究的市場規模將從 2026 年的 63.8 億美元成長到 2031 年的 92.4 億美元，複合年成長率為 7.7%。
推動這一市場成長的幾個關鍵因素塑造了獸藥研發、生物製藥生產和精準動物醫學的未來。
| 調查範圍 | |
|---|---|
| 調查期 | 2024-2031 |
| 基準年 | 2025 |
| 預測期 | 2026-2031 |
| 單元 | 金額（美元） |
| 部分 | 依服務、產品類型、動物類型、最終用戶、地區 |
| 目標區域 | 北美、歐洲、亞太地區、拉丁美洲、中東和非洲 |
推動這一成長的主要因素是動物保健公司對研發和生產服務外包的需求日益成長，因為這些公司希望加快產品平臺、降低內部成本，並獲得生物製藥、疫苗和先進製劑等複雜療法的專業知識。隨著動物醫療產業轉向更具針對性、數據驅動的治療方法，對高品質研究、分析測試和符合GMP規範的生產的需求正在迅速成長。此外，通用動物和家畜慢性病、感染疾病和感染疾病負擔的加重，也推動了對更快、更有效率的研發流程的需求。 CDMO和CRO透過提供可擴展的生產、高通量篩檢和先進的研究能力，在滿足這些需求方面發揮著至關重要的作用。動物保健領域持續的現代化趨勢，包括採用即時監測工具、數位化工作流程和改進臨床試驗管理，進一步增強了對專業外包合作夥伴的依賴。
人工智慧在預測建模中的應用、生物製程的自動化以及先進分析平台的開發等技術進步也在推動市場成長。這些創新提高了準確性，縮短了研發週期，並擴大了臨床前、臨床和商業化階段外包服務的範圍。總體而言，不斷成長的行業需求、技術進步以及向專業化和外包專業知識的轉變，正在推動動物保健行業的契約製造和合約研究市場實現強勁且持續的成長。
“按動物類型分類，預計伴侶動物細分市場在預測期內將以最高的複合年成長率成長。”
受寵物飼養量增加、先進治療支出成長以及對犬貓創新療法需求不斷成長的推動，預計該領域將實現最高成長。癌症、肥胖、過敏和慢性病等疾病在寵物中日益普遍，推動了對新藥、生物製藥和特殊配方的需求。寵物飼主願意為寵物提供高品質的護理，加上寵物「人性化」觀念的興起和保險覆蓋範圍的擴大，促使動物保健公司開發更複雜的產品，導致研發、生產和臨床試驗更多地外包給合約研發生產機構（CDMO）和合約研究機構（CRO）。
“按最終用戶分類，到 2024 年，跨國動物保健公司將佔據最大的市場佔有率。”
2024年，跨國動物保健公司板塊引領市場成長，這些公司擁有豐富的產品平臺，經營符合全球標準的供應鏈，並持續投資於先進療法、疫苗和診斷技術的研發。其廣泛的產品組合和高產量催生了對專業外包合作夥伴的強勁需求，這些合作夥伴能夠支持製劑開發、規模化生產、分析測試和臨床研究。此外，這些公司越來越依賴合約研發生產機構（CDMO）和合約研究機構（CRO）來加快產品上市速度、擴大產能並取得最尖端科技，從而成為推動整體市場需求的主要動力。
“預計亞太地區在預測期內將呈現最高的成長率。”
亞太地區預計將成為成長最快的地區，這主要得益於中國、印度和東南亞等國家畜牧業產量的成長、寵物飼養量的增加以及對動物健康基礎設施投資的擴大。該地區獸藥生產也正經歷快速擴張，先進生技藥品和診斷技術的應用日益普及，政府對疾病管制和疫苗接種計畫的支持力度也不斷增加。此外，營運成本的降低、法規結構的完善以及本地合約研發生產機構（CDMO）和合約研究機構（CRO）的湧現，正促使全球動物保健公司擴大將研發和生產業務外包給亞太地區，從而加速該地區的成長。
本報告考察了全球動物醫療契約製造和研究市場，提供了市場概述、影響市場成長的各種因素分析、技術和專利趨勢、法律制度、案例研究、市場規模趨勢和預測、按各個細分市場和地區/主要國家進行的詳細分析、競爭格局以及主要企業的概況。
目錄
第1章：引言
第2章執行摘要
第3章重要考察
第4章 市場概覽
- 市場動態
- 促進因素
- 抑制因子
- 市場機遇
- 任務
- 未滿足的需求和閒置頻段
- 與相關市場和不同產業相關的跨領域機遇
- 一、二、三級企業的策略性舉措
第5章 產業趨勢
- 波特五力分析
- 總體經濟指標
- 供應鏈分析
- 價值鏈分析
- 生態系分析
- 價格分析
- 2026-2027 年主要會議和活動
- 影響我們客戶公司業務的趨勢/變化
- 投資和資金籌措場景
- 成功案例和實際應用
第6章：透過採用技術、專利、數位技術和人工智慧實現策略性顛覆性創新
- 技術分析
- 關鍵新興技術
- 互補技術
- 鄰近技術
- 技術/產品藍圖
- 專利分析
- 未來應用
- 先進的生技藥品和疫苗生產平台
- 利用人工智慧、遠端監測和真實世界數據數位化、數據豐富的臨床開發。
- 因應全球化趨勢，發展符合監管要求，並建立統一的品質和製造系統。
- 針對緩釋、物種特異性和難以給藥的產品，開發創新的製劑技術。
- 人工智慧/生成式人工智慧對動物醫療契約製造和研究市場的影響。
第7章永續性和監管情勢
- 當地法規和合規性
- 對永續性的承諾
第8章：顧客趨勢與購買行為
- 主要相關利益者和採購標準
- 客戶趨勢和購買行為
第9章：動物保健契約製造和研究市場（按服務分類）
- CRO 服務
- 藥物發現與臨床前試驗
- 獸醫臨床試驗
- 分析及生物分析服務及品質保證
- 監理服務與諮詢
- CDMO 服務
- 製程原料藥及製劑開發
- 製造業
- 包裝和標籤
- 品質、穩定性和售後支持
第10章：動物保健契約製造與研究市場：依產品類型分類
- 製藥
- 小分子藥物
- 動物用藥品、生技藥品和疫苗
- 含藥飼料和補充劑
- 醫療設備
- 診斷設備
- 監控系統
- 植入
第11章：動物醫藥契約製造與研究市場：依動物類型分類
- 伴侶動物
- 狗
- 貓
- 馬
- 其他寵物
- 家畜
- 牛
- 豬
- 家禽
- 綿羊和山羊
- 其他牲畜
第12章：動物保健契約製造與研究市場：依最終用戶分類
- 跨國動物用藥品公司
- 中型/專業動物保健公司
- Start-Ups公司和動物醫療生物技術公司
第13章：動物保健契約製造與合約研究市場：按地區分類
- 北美洲
- 宏觀經濟展望
- 市場規模趨勢與預測（數量）：依產品類型分類
- 市場規模趨勢與預測（價值）
- 美國
- 加拿大
- 歐洲
- 宏觀經濟展望
- 市場規模趨勢與預測（數量）：依產品類型分類
- 市場規模趨勢與預測（價值）
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 其他
- 亞太地區
- 宏觀經濟展望
- 市場規模趨勢與預測（數量）：依產品類型分類
- 市場規模趨勢與預測（價值）
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 泰國
- 紐西蘭
- 其他
- 拉丁美洲
- 宏觀經濟展望
- 市場規模趨勢與預測（數量）：依產品類型分類
- 市場規模趨勢與預測（價值）
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
- 中東和非洲
- 宏觀經濟展望
- 市場規模趨勢與預測（數量）：依產品類型分類
- 市場規模趨勢與預測（價值）
- 海灣合作理事會國家
- 其他
第14章 競爭格局
- 概述
- 主要參與企業的策略/優勢
- 收入分析
- 動物保健合約研究組織：市場佔有率分析
- 獸藥CDMO：市場佔有率分析
- 公司評估矩陣：主要動物保健合約研究組織
- 公司評估矩陣：動物保健CROStart-Ups/中小企業
- 公司評估矩陣：主要動物保健CDMO
- 公司評估矩陣：動物保健CDMOStart-Ups/中小企業
- 服務比較分析
- 企業估值和財務指標
- 競爭格局
第15章：公司簡介
- CDMO
- 主要企業
- 其他公司
- CRO
- 主要企業
- 其他公司
第16章調查方法
第17章附錄
Product Code: MD 10278
The veterinary contract manufacturing & research market is expected to grow from USD 6.38 billion in 2026 to USD 9.24 billion by 2031, at a CAGR of 7.7%. The market growth is driven by several key factors shaping the future of veterinary drug development, biologics manufacturing, and precision animal health.
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2024-2031 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD billion) |
| Segments | By Service, Product Type, Animal Type, End User, Region |
| Regions covered | North America, Europe,Asia Pacific, Latin America, Middle East & Africa |
A major driver of this growth is the increasing demand for outsourced development and manufacturing services as animal health companies seek to accelerate product pipelines, reduce internal costs, and access specialized expertise for complex therapeutics such as biologics, vaccines, and advanced formulations. As the veterinary industry shifts toward more targeted, data-driven treatment approaches, the need for high-quality research, analytical testing, and GMP-compliant production is rapidly rising. Additionally, the growing burden of chronic, infectious, and zoonotic diseases in both companion and livestock animals is driving demand for faster and more efficient research and development (R&D) processes. CDMOs and CROs play a critical role in meeting this need by providing scalable manufacturing, high-throughput screening, and advanced study capabilities. The ongoing trend toward modernization in veterinary healthcare, including the adoption of real-time monitoring tools, digital workflows, and improved clinical trial management, further strengthens reliance on specialized outsourcing partners.
Technological advancements, including the integration of AI for predictive modeling, automation in bioprocessing, and the development of enhanced analytical platforms, also drive market growth. These innovations enhance accuracy, shorten development timelines, and expand the applications of outsourced services across preclinical, clinical, and commercial phases. Overall, rising industry demands, advancements in technology, and the growing shift toward specialized and outsourced expertise are driving strong and sustained growth in the veterinary contract manufacturing & research market.
"By animal type, the companion animals segment is projected to grow at the highest CAGR during the forecast period."
The software & services segment is expected to see the highest growth in the veterinary contract manufacturing & research market, due to rising pet ownership, increasing spending on advanced treatments, and growing demand for innovative therapeutics for dogs and cats. Conditions such as cancer, obesity, allergies, and chronic diseases are becoming more prevalent in pets, driving the need for new drugs, biologics, and specialty formulations. Pet owners' willingness to invest in premium care, coupled with the humanization of pets and expanding insurance coverage, is encouraging animal health companies to develop more complex products-leading to greater outsourcing of R&D, manufacturing, and clinical studies to CDMOs and CROs.
"By end user, the multinational animal-health companies segment accounted for the largest market share in 2024."
In 2024, the veterinary clinics segment dominated the veterinary contract manufacturing & research market because they manage extensive product pipelines, operate globally regulated supply chains, and consistently invest in developing advanced therapeutics, vaccines, and diagnostics. Their broad portfolios and high production volumes create a strong need for specialized outsourcing partners to support formulation, scale-up, analytical testing, and clinical research. Additionally, these companies increasingly rely on CDMOs and CROs to accelerate time-to-market, expand manufacturing capacity, and access cutting-edge technologies, making them the primary contributors to overall market demand.
"The Asia Pacific region is projected to witness the highest growth rate during the forecast period."
The Asia Pacific is expected to experience the highest growth in the veterinary contract manufacturing & research market, driven by rising livestock production, increasing pet ownership, and growing investment in animal health infrastructure across countries such as China, India, and Southeast Asia. The region is witnessing rapid expansion of veterinary pharmaceutical manufacturing, greater adoption of advanced biologics and diagnostics, and stronger government support for disease control and vaccination programs. Additionally, lower operational costs, improving regulatory frameworks, and the emergence of local CDMOs and CROs are attracting global animal health companies to outsource more research and manufacturing to APAC, driving its accelerated growth.
Breakdown of supply-side primary interviews:
- By Company Type: Tier 1 (60%), Tier 2 (30%), and Tier 3 (10%)
- By Designation: C-level Executives (30%), Directors (50%), and Other Designations (20%)
- By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)
Breakdown of demand-side primary interviews:
- By End User: Multinational animal-health companies (59%), mid-sized / specialty animal-health firms (26%), and start-ups & veterinary biotech firms (15%)
- By Designation: R&D directors/heads of research (47%), product development & innovation managers (22%), regulatory affairs managers/directors (15%), and others (16%)
- By Region: North America (25%), Europe (24%), Asia Pacific (25%), Latin America (11%), and the Middle East & Africa (15%)
Research Coverage
The market study covers the veterinary contract manufacturing & research market in various segments. It aims to estimate the market size and growth potential of this market by service, product type, animal type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their products and business offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report can help established companies and newer or smaller firms understand market trends, enabling them to capture a larger market share. Firms that acquire the report can implement one or more of the five strategies outlined below.
This report provides insights into the following points:
- Analysis of key drivers (growth in animal health spending, increasing complexity of veterinary biologics and the increasing regulatory burden for GMP, biosecurity & environmental compliance.), restraints (limited specialized infrastructure and long approval timelines & regulatory diversity globally), opportunities (geographic expansion into emerging markets, digital CRO services), and challenges (difficulty in clinical trial recruitment and difficulty in scaling sterile/biologics capacity quickly) influencing the growth of the veterinary contract manufacturing & research market
- Product Development/Innovation: Detailed insights on upcoming technologies and service launches in the veterinary contract manufacturing & research market
- Market Development: Comprehensive information about lucrative emerging markets; the report analyzes the markets for various types of veterinary CDMO & CRO services across regions
- Market Diversification: Exhaustive information about services, untapped regions, recent developments, and investments in the veterinary contract manufacturing & research market
- Competitive Assessment: In-depth assessment of market shares, strategies, services, distribution networks, and manufacturing capabilities of the leading players in the veterinary contract manufacturing & research market
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 STUDY SCOPE
- 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.4 MARKET STAKEHOLDERS
- 1.5 LIMITATIONS
2 EXECUTIVE SUMMARY
3 PREMIUM INSIGHTS
- 3.1 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET OVERVIEW
- 3.2 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE & COUNTRY (2025)
- 3.3 VETERINARY CROS MARKET: REGIONAL MIX
- 3.4 VETERINARY CDMOS MARKET: REGIONAL MIX
- 3.5 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
- 3.6 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: DEVELOPED VS. EMERGING ECONOMIES
4 MARKET OVERVIEW
- 4.1 INTRODUCTION
- 4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
- 4.2.1.1 Growth in animal health spending
- 4.2.1.2 Increasing complexity of veterinary biologics
- 4.2.1.3 Rising regulatory requirements for GMP, biosecurity, and environmental compliance
- 4.2.2 RESTRAINTS
- 4.2.2.1 Limited specialized infrastructure
- 4.2.2.2 Long approval timelines & regulatory diversity globally
- 4.2.3 OPPORTUNITIES
- 4.2.3.1 Geographic expansion into emerging markets
- 4.2.3.2 Digital CRO services
- 4.2.4 CHALLENGES
- 4.2.4.1 Challenges in clinical trial recruitment
- 4.2.4.2 Difficulty in scaling sterile/biologics capacity quickly
- 4.2.1 DRIVERS
- 4.3 UNMET NEEDS & WHITE SPACES
- 4.3.1 UNMET NEEDS IN VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET
- 4.3.2 WHITE SPACE OPPORTUNITIES
- 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
- 4.4.1 INTERCONNECTED MARKETS
- 4.4.2 CROSS-SECTOR OPPORTUNITIES
- 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
- 4.5.1 UNMET NEEDS IN VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET
5 INDUSTRY TRENDS
- 5.1 PORTER'S FIVE FORCES ANALYSIS
- 5.1.1 THREAT OF NEW ENTRANTS
- 5.1.2 THREAT OF SUBSTITUTES
- 5.1.3 BARGAINING POWER OF SUPPLIERS
- 5.1.4 BARGAINING POWER OF BUYERS
- 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.2 MACROECONOMIC INDICATORS
- 5.2.1 INTRODUCTION
- 5.2.2 GDP TRENDS & FORECAST
- 5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY
- 5.2.4 TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY
- 5.3 SUPPLY CHAIN ANALYSIS
- 5.4 VALUE CHAIN ANALYSIS
- 5.5 ECOSYSTEM ANALYSIS
- 5.6 PRICING ANALYSIS
- 5.6.1 AVERAGE SELLING PRICE TREND OF API & FILL-FINISH PHARMACEUTICALS & BIOLOGICS, BY KEY PLAYER, 2023-2025
- 5.6.2 AVERAGE SELLING PRICE TREND OF API & FILL-FINISH PHARMACEUTICALS & BIOLOGICS, BY REGION, 2023-2025
- 5.6.2.1 Average selling price trend of small-molecule pharmaceuticals for API/drug substance manufacturing, by region, 2023-2025
- 5.6.2.2 Average selling price trend of small-molecule pharmaceuticals for fill-finish/drug product manufacturing, by region, 2023-2025
- 5.6.2.3 Average selling price trend of animal health biologics & vaccines for API/drug substance manufacturing, by region, 2023-2025
- 5.6.2.4 Average selling price trend of animal health biologics & vaccines for fill-finish/drug product manufacturing, by region, 2023-2025
- 5.7 KEY CONFERENCES & EVENTS, 2026-2027
- 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- 5.9 INVESTMENT & FUNDING SCENARIO
- 5.10 SUCCESS STORIES & REAL-WORLD APPLICATIONS
- 5.10.1 END-TO-END CDMO SUPPORT FOR ANIMAL HEALTH LATERAL FLOW DIAGNOSTICS
- 5.10.2 END-TO-END CDMO SUPPORT FOR FIRST-IN-CLASS VETERINARY MONOCLONAL ANTIBODY (MAB)
- 5.10.3 END-TO-END BIOLOGICS OPTIMIZATION FOR CANINE ANTIBODY PROGRAMS
6 STRATEGIC DISRUPTIONS THROUGH TECHNOLOGY, PATENTS, AND DIGITAL & AI ADOPTION
- 6.1 TECHNOLOGY ANALYSIS
- 6.1.1 KEY EMERGING TECHNOLOGIES
- 6.1.1.1 High-throughput in vitro & in vivo screening platforms
- 6.1.1.2 AI/ML platforms for drug discovery
- 6.1.2 COMPLEMENTARY TECHNOLOGIES
- 6.1.2.1 Laboratory automation, robotics, and smart QC systems
- 6.1.2.2 Stability, cold chain, and packaging optimization technologies
- 6.1.3 ADJACENT TECHNOLOGIES
- 6.1.3.1 Digital therapeutics & software-as-a-medical-device (SaMD)
- 6.1.3.2 Precision livestock technologies
- 6.1.1 KEY EMERGING TECHNOLOGIES
- 6.2 TECHNOLOGY/PRODUCT ROADMAP
- 6.2.1 NEAR TERM (2025-2027)
- 6.2.2 MID TERM (2028-2030)
- 6.2.3 LONG TERM (2030+)
- 6.3 PATENT ANALYSIS
- 6.3.1 PATENT PUBLICATION TRENDS FOR VETERINARY PHARMACEUTICALS
- 6.3.2 JURISDICTION & TOP APPLICANT ANALYSIS
- 6.4 FUTURE APPLICATIONS
- 6.4.1 ADVANCED BIOLOGICS & VACCINE MANUFACTURING PLATFORMS
- 6.4.2 DIGITALIZED, DATA-RICH CLINICAL DEVELOPMENT USING AI, REMOTE MONITORING, AND REAL-WORLD DATA
- 6.4.3 GLOBALIZED, REGULATORY-READY DEVELOPMENT WITH HARMONIZED QUALITY & MANUFACTURING SYSTEMS
- 6.4.4 INNOVATIVE FORMULATION TECHNOLOGIES FOR LONG-ACTING, SPECIES-TAILORED, AND DIFFICULT-TO-DELIVER PRODUCTS
- 6.5 IMPACT OF AI/GENERATIVE AI ON VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET
- 6.5.1 INTRODUCTION
- 6.5.2 MARKET POTENTIAL IN VETERINARY CONTRACT MANUFACTURING & RESEARCH ECOSYSTEM
- 6.5.3 AI USE CASES
- 6.5.4 KEY COMPANIES IMPLEMENTING AI IN VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET
7 SUSTAINABILITY & REGULATORY LANDSCAPE
- 7.1 REGIONAL REGULATIONS & COMPLIANCE
- 7.1.1 REGULATORY ANALYSIS
- 7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 7.1.3 INDUSTRY STANDARDS
- 7.2 SUSTAINABILITY INITIATIVES
- 7.2.1 RECYCLED AND ECO-FRIENDLY MATERIALS FOR VETERINARY PRODUCTS
- 7.2.2 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
- 7.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
- 8.1 KEY STAKEHOLDERS & BUYING CRITERIA
- 8.1.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 8.1.2 BUYING CRITERIA
- 8.2 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
- 8.2.1 DECISION-MAKING PROCESS
- 8.2.2 ADOPTION BARRIERS & INTERNAL CHALLENGES
- 8.2.3 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
- 8.2.4 MARKET PROFITABILITY
9 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE
- 9.1 INTRODUCTION
- 9.2 CRO SERVICES
- 9.2.1 DISCOVERY & PRE-CLINICAL STUDIES
- 9.2.1.1 Growing use of discovery & pre-clinical studies to accelerate veterinary drug pipeline initiation
- 9.2.2 VETERINARY CLINICAL TRIALS
- 9.2.2.1 Growing dependence on veterinary clinical trials to validate safety and efficacy for regulatory approvals to boost market
- 9.2.3 ANALYTICAL & BIOANALYTICAL SERVICES AND QUALITY ASSURANCE
- 9.2.3.1 Rising adoption of analytical & bioanalytical services to ensure high-quality, compliant veterinary products to fuel growth
- 9.2.4 REGULATORY AFFAIRS & CONSULTING
- 9.2.4.1 Increasing need for regulatory affairs & consulting to navigate complex global veterinary approval pathways to support growth
- 9.2.1 DISCOVERY & PRE-CLINICAL STUDIES
- 9.3 CDMO SERVICES
- 9.3.1 PROCESS API & FORMULATION DEVELOPMENT
- 9.3.1.1 Growing focus on process API & formulation development to optimize veterinary product performance to drive growth
- 9.3.2 MANUFACTURING
- 9.3.2.1 Increasing outsourcing of manufacturing to scale production of veterinary drugs and biologics
- 9.3.3 PACKAGING & LABELING
- 9.3.3.1 Rising dependence on packaging & labeling services to ensure regulatory-compliant product delivery to propel market
- 9.3.4 QUALITY/STABILITY & POST-MARKET SUPPORT
- 9.3.4.1 Expanding use of quality, stability, and post-market support to maintain lifecycle product compliance to boost market
- 9.3.1 PROCESS API & FORMULATION DEVELOPMENT
10 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE
- 10.1 INTRODUCTION
- 10.2 MEDICINES
- 10.2.1 SMALL-MOLECULE PHARMACEUTICALS
- 10.2.1.1 API/Drug substance manufacturing
- 10.2.1.1.1 Growing focus on API manufacturing to support market growth
- 10.2.1.1.2 Global volume analysis of small-molecule pharmaceuticals market for API/drug substance manufacturing, by type, 2024-2031 (metric tons)
- 10.2.1.2 Fill-finish/drug product manufacturing
- 10.2.1.2.1 Increasing demand for fill-finish operations to fuel market growth
- 10.2.1.2.2 Global volume analysis of small-molecule pharmaceuticals market for fill-finish/drug product manufacturing, by type, 2024-2031 (ten thousand units)
- 10.2.1.1 API/Drug substance manufacturing
- 10.2.2 ANIMAL HEALTH BIOLOGICS & VACCINES
- 10.2.2.1 API/Drug substance manufacturing
- 10.2.2.1.1 Rising demand for API/drug substance manufacturing to drive growth
- 10.2.2.1.2 Global volume analysis of animal health biologics & vaccines for API/drug substance manufacturing, by type, 2024-2031 (metric tons)
- 10.2.2.2 Fill-finish/drug product manufacturing
- 10.2.2.2.1 Rising dependence on fill-finish capabilities to fuel growth
- 10.2.2.2.2 Global volume analysis of animal health biologics & vaccines market for fill-finish/drug product manufacturing, by type, 2024-2031 (thousand units)
- 10.2.2.1 API/Drug substance manufacturing
- 10.2.3 MEDICATED FEED & SUPPLEMENTS
- 10.2.3.1 Rising use of medicated feed & supplements to enhance livestock health and productivity
- 10.2.1 SMALL-MOLECULE PHARMACEUTICALS
- 10.3 MEDICAL DEVICES
- 10.3.1 DIAGNOSTICS
- 10.3.1.1 Growing adoption of veterinary diagnostics to drive market growth
- 10.3.2 MONITORING SYSTEMS
- 10.3.2.1 Expanding utilization of monitoring systems to improve real-time animal health management to fuel growth
- 10.3.3 IMPLANTS
- 10.3.3.1 Increasing use of veterinary implants to support long-term treatment and orthopedic care to drive growth
- 10.3.1 DIAGNOSTICS
11 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE
- 11.1 INTRODUCTION
- 11.2 COMPANION ANIMALS
- 11.2.1 DOGS
- 11.2.1.1 High adoption rates of dogs to drive market growth
- 11.2.2 CATS
- 11.2.2.1 Rising disease prevalence among cats to drive market
- 11.2.3 HORSES
- 11.2.3.1 Growing equine population to support market growth
- 11.2.4 OTHER COMPANION ANIMALS
- 11.2.1 DOGS
- 11.3 LIVESTOCK ANIMALS
- 11.3.1 CATTLE
- 11.3.1.1 Growing consumption of meat to drive market
- 11.3.2 SWINE
- 11.3.2.1 Growing incidence of infectious diseases to drive market
- 11.3.3 POULTRY
- 11.3.3.1 Increasing demand for poultry meat to contribute to market growth
- 11.3.4 SHEEP & GOATS
- 11.3.4.1 Growing global demand for wool to drive market
- 11.3.5 OTHER LIVESTOCK ANIMALS
- 11.3.1 CATTLE
12 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER
- 12.1 INTRODUCTION
- 12.2 MULTINATIONAL ANIMAL HEALTH COMPANIES
- 12.2.1 INCREASED OUTSOURCING BY MULTINATIONAL ANIMAL HEALTH COMPANIES TO EXPAND GLOBAL PRODUCT DEVELOPMENT
- 12.3 MID-SIZED/SPECIALTY ANIMAL HEALTH FIRMS
- 12.3.1 RISING RELIANCE OF MID-SIZED & SPECIALTY ANIMAL HEALTH FIRMS ON CDMO/CRO PARTNERS TO BOOST PIPELINES
- 12.4 START-UPS & VETERINARY BIOTECH FIRMS
- 12.4.1 GROWING ENGAGEMENT OF START-UPS & VETERINARY BIOTECH FIRMS TO ACCESS ADVANCED DEVELOPMENT CAPABILITIES
13 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY REGION
- 13.1 INTRODUCTION
- 13.2 NORTH AMERICA
- 13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 13.2.2 NORTH AMERICA: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024-2031
- 13.2.3 NORTH AMERICA: VALUE ANALYSIS, 2024-2031
- 13.2.4 US
- 13.2.4.1 Rising pet population to drive demand
- 13.2.5 CANADA
- 13.2.5.1 Rising pet adoption rate to drive market
- 13.3 EUROPE
- 13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 13.3.2 EUROPE: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024-2031
- 13.3.3 EUROPE: VALUE ANALYSIS, 2024-2031
- 13.3.4 GERMANY
- 13.3.4.1 Germany to dominate European market during forecast period
- 13.3.5 UK
- 13.3.5.1 Increasing pet ownership to drive market growth
- 13.3.6 FRANCE
- 13.3.6.1 Rising cases of zoonotic diseases to drive market growth
- 13.3.7 ITALY
- 13.3.7.1 Growing livestock population to support market growth
- 13.3.8 SPAIN
- 13.3.8.1 Increasing animal healthcare expenditure to drive market growth
- 13.3.9 NETHERLANDS
- 13.3.9.1 Increasing companion animal population to drive market growth
- 13.3.10 REST OF EUROPE
- 13.4 ASIA PACIFIC
- 13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 13.4.2 ASIA PACIFIC: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024-2031
- 13.4.3 ASIA PACIFIC: VALUE ANALYSIS, 2024-2031
- 13.4.4 CHINA
- 13.4.4.1 China to dominate APAC market during forecast period
- 13.4.5 JAPAN
- 13.4.5.1 Aging pet population to drive market
- 13.4.6 INDIA
- 13.4.6.1 Rising livestock population to boost market growth
- 13.4.7 AUSTRALIA
- 13.4.7.1 Rising livestock animal population and increasing pet ownership to support market growth
- 13.4.8 SOUTH KOREA
- 13.4.8.1 Increasing demand for preventive care and aging pet population to drive market
- 13.4.9 THAILAND
- 13.4.9.1 Increasing demand for preventive care and aging pet population to drive market
- 13.4.10 NEW ZEALAND
- 13.4.10.1 High biosecurity standards to drive market
- 13.4.11 REST OF ASIA PACIFIC
- 13.5 LATIN AMERICA
- 13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 13.5.2 LATIN AMERICA: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024-2031
- 13.5.3 LATIN AMERICA: VALUE ANALYSIS, 2024-2031
- 13.5.4 BRAZIL
- 13.5.4.1 Brazil to dominate LATAM market due to rapidly increasing livestock population
- 13.5.5 MEXICO
- 13.5.5.1 Rising demand for animal-derived food products to contribute to market growth
- 13.5.6 ARGENTINA
- 13.5.6.1 Rising livestock population to fuel market growth
- 13.5.7 REST OF LATIN AMERICA
- 13.6 MIDDLE EAST & AFRICA
- 13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
- 13.6.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024-2031
- 13.6.3 MIDDLE EAST & AFRICA: VALUE ANALYSIS, 2024-2031
- 13.6.4 GCC COUNTRIES
- 13.6.4.1 Kingdom of Saudi Arabia (KSA)
- 13.6.4.1.1 Technological advancements & government initiatives to boost growth
- 13.6.4.2 United Arab Emirates (UAE)
- 13.6.4.2.1 Government support and high livestock population to fuel UAE's market growth
- 13.6.4.3 Rest of GCC Countries
- 13.6.4.1 Kingdom of Saudi Arabia (KSA)
- 13.6.5 REST OF MIDDLE EAST & AFRICA
14 COMPETITIVE LANDSCAPE
- 14.1 OVERVIEW
- 14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 14.3 REVENUE ANALYSIS, 2021-2025
- 14.3.1 KEY VETERINARY CONTRACT RESEARCH ORGANIZATIONS
- 14.3.2 KEY VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS
- 14.4 VETERINARY CRO MARKET SHARE ANALYSIS, 2025
- 14.4.1 GLOBAL MARKET SHARE ANALYSIS OF VETERINARY CONTRACT RESEARCH ORGANIZATIONS, 2025
- 14.4.2 RANKING OF KEY MARKET PLAYERS
- 14.4.3 US MARKET SHARE ANALYSIS OF VETERINARY CONTRACT RESEARCH ORGANIZATIONS, 2025
- 14.4.4 EUROPE MARKET SHARE ANALYSIS OF VETERINARY CONTRACT RESEARCH ORGANIZATIONS, 2025
- 14.5 VETERINARY CDMO MARKET SHARE ANALYSIS, 2025
- 14.5.1 GLOBAL MARKET SHARE ANALYSIS OF VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, 2025
- 14.5.2 RANKING OF KEY MARKET PLAYERS
- 14.5.3 US MARKET SHARE ANALYSIS OF VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, 2025
- 14.5.4 EUROPE MARKET SHARE ANALYSIS OF VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, 2025
- 14.6 COMPANY EVALUATION MATRIX: KEY VETERINARY CROS, 2025
- 14.6.1 STARS
- 14.6.2 EMERGING LEADERS
- 14.6.3 PERVASIVE PLAYERS
- 14.6.4 PARTICIPANTS
- 14.6.5 COMPANY FOOTPRINT: KEY VETERINARY CROS, 2025
- 14.6.5.1 Company footprint
- 14.6.5.2 Region footprint
- 14.6.5.3 Service footprint
- 14.6.5.4 Product type footprint
- 14.6.5.5 Animal type footprint
- 14.7 COMPANY EVALUATION MATRIX: VETERINARY CRO STARTUPS/SMES, 2025
- 14.7.1 PROGRESSIVE COMPANIES
- 14.7.2 RESPONSIVE COMPANIES
- 14.7.3 DYNAMIC COMPANIES
- 14.7.4 STARTING BLOCKS
- 14.7.5 COMPETITIVE BENCHMARKING: VETERINARY CRO STARTUPS/SMES, 2025
- 14.7.5.1 Detailed list of key veterinary CRO startups/SMEs
- 14.7.5.2 Competitive benchmarking of key veterinary CRO startups/SMEs
- 14.8 COMPANY EVALUATION MATRIX: VETERINARY CDMOS, 2025
- 14.8.1 STARS
- 14.8.2 EMERGING LEADERS
- 14.8.3 PERVASIVE PLAYERS
- 14.8.4 PARTICIPANTS
- 14.8.5 COMPANY FOOTPRINT: KEY VETERINARY CDMOS, 2025
- 14.8.5.1 Company footprint
- 14.8.5.2 Region footprint
- 14.8.5.3 Service footprint
- 14.8.5.4 Product type footprint
- 14.8.5.5 Animal type footprint
- 14.9 COMPANY EVALUATION MATRIX: VETERINARY CDMO STARTUPS/SMES, 2025
- 14.9.1 PROGRESSIVE COMPANIES
- 14.9.2 RESPONSIVE COMPANIES
- 14.9.3 DYNAMIC COMPANIES
- 14.9.4 STARTING BLOCKS
- 14.9.5 COMPETITIVE BENCHMARKING: VETERINARY CDMO STARTUPS/SMES, 2025
- 14.9.5.1 Detailed list of key veterinary CDMO startups/SMEs
- 14.9.5.2 Competitive benchmarking of key veterinary CDMO startups/SMEs
- 14.10 SERVICE COMPARATIVE ANALYSIS
- 14.11 COMPANY VALUATION & FINANCIAL METRICS
- 14.11.1 FINANCIAL METRICS
- 14.11.2 COMPANY VALUATION
- 14.12 COMPETITIVE SCENARIO
- 14.12.1 SERVICE LAUNCHES & APPROVALS
- 14.12.2 DEALS
- 14.12.3 EXPANSIONS
- 14.12.4 OTHER DEVELOPMENTS
15 COMPANY PROFILES
- 15.1 CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS
- 15.1.1 KEY PLAYERS
- 15.1.1.1 Argenta Holdco Limited
- 15.1.1.1.1 Business overview
- 15.1.1.1.2 Services offered
- 15.1.1.1.3 Recent developments
- 15.1.1.1.3.1 Service launches & upgrades
- 15.1.1.1.3.2 Deals
- 15.1.1.1.3.3 Expansions
- 15.1.1.1.4 MnM view
- 15.1.1.1.4.1 Key strengths
- 15.1.1.1.4.2 Strategic choices
- 15.1.1.1.4.3 Weaknesses & competitive threats
- 15.1.1.2 Aenova Group
- 15.1.1.2.1 Business overview
- 15.1.1.2.2 Services offered
- 15.1.1.2.3 Recent developments
- 15.1.1.2.3.1 Expansions
- 15.1.1.2.3.2 Other developments
- 15.1.1.2.4 MnM view
- 15.1.1.2.4.1 Key strengths
- 15.1.1.2.4.2 Strategic choices
- 15.1.1.2.4.3 Weaknesses & competitive threats
- 15.1.1.3 FAREVA SA
- 15.1.1.3.1 Business overview
- 15.1.1.3.2 Services offered
- 15.1.1.3.3 MnM view
- 15.1.1.3.3.1 Key strengths
- 15.1.1.3.3.2 Strategic choices
- 15.1.1.3.3.3 Weaknesses & competitive threats
- 15.1.1.4 Vetio
- 15.1.1.4.1 Business overview
- 15.1.1.4.2 Services offered
- 15.1.1.4.3 MnM view
- 15.1.1.4.3.1 Key strengths
- 15.1.1.4.3.2 Strategic choices
- 15.1.1.4.3.3 Weaknesses & competitive threats
- 15.1.1.5 TriRx Pharmaceutical Services
- 15.1.1.5.1 Business overview
- 15.1.1.5.2 Services offered
- 15.1.1.5.3 MnM view
- 15.1.1.5.3.1 Key strengths
- 15.1.1.5.3.2 Strategic choices
- 15.1.1.5.3.3 Weaknesses & competitive threats
- 15.1.1.6 Indian Immunologicals Ltd.
- 15.1.1.6.1 Business overview
- 15.1.1.6.2 Services offered
- 15.1.1.7 Recipharm AB
- 15.1.1.7.1 Business overview
- 15.1.1.7.2 Services offered
- 15.1.1.7.3 Recent developments
- 15.1.1.7.3.1 Technology launches
- 15.1.1.7.3.2 Deals
- 15.1.1.7.3.3 Expansions
- 15.1.1.7.3.4 Other developments
- 15.1.1.8 LABIANA
- 15.1.1.8.1 Business overview
- 15.1.1.8.2 Services offered
- 15.1.1.8.3 Recent developments
- 15.1.1.8.3.1 Other developments
- 15.1.1.9 Syngene International Limited
- 15.1.1.9.1 Business overview
- 15.1.1.9.2 Services offered
- 15.1.1.9.3 Recent developments
- 15.1.1.9.3.1 Deals
- 15.1.1.9.3.2 Other developments
- 15.1.1.10 CZ Vaccines
- 15.1.1.10.1 Business overview
- 15.1.1.10.2 Services offered
- 15.1.1.1 Argenta Holdco Limited
- 15.1.2 OTHER PLAYERS
- 15.1.2.1 AB7 Group
- 15.1.2.2 Kela Health
- 15.1.2.3 Eirgen Pharma
- 15.1.2.4 Bioingenium
- 15.1.2.5 Elise Biopharma
- 15.1.1 KEY PLAYERS
- 15.2 CONTRACT RESEARCH ORGANIZATIONS
- 15.2.1 KEY PLAYERS
- 15.2.1.1 Labcorp
- 15.2.1.1.1 Business overview
- 15.2.1.1.2 Services offered
- 15.2.1.1.3 Recent developments
- 15.2.1.1.3.1 Technology launches
- 15.2.1.1.3.2 Expansions
- 15.2.1.1.4 MnM view
- 15.2.1.1.4.1 Key strengths
- 15.2.1.1.4.2 Strategic choices
- 15.2.1.1.4.3 Weaknesses & competitive threats
- 15.2.1.2 Eurofins Scientific
- 15.2.1.2.1 Business overview
- 15.2.1.2.2 Services offered
- 15.2.1.2.3 Recent developments
- 15.2.1.2.3.1 Deals
- 15.2.1.2.4 MnM view
- 15.2.1.2.4.1 Key strengths
- 15.2.1.2.4.2 Strategic choices
- 15.2.1.2.4.3 Weaknesses & competitive threats
- 15.2.1.3 Charles River Laboratories
- 15.2.1.3.1 Business overview
- 15.2.1.3.2 Services offered
- 15.2.1.3.3 MnM view
- 15.2.1.3.3.1 Key strengths
- 15.2.1.3.3.2 Strategic choices
- 15.2.1.3.3.3 Weaknesses & competitive threats
- 15.2.1.4 Knoell Germany GmbH
- 15.2.1.4.1 Business overview
- 15.2.1.4.2 Services offered
- 15.2.1.4.3 Recent developments
- 15.2.1.4.3.1 Deals
- 15.2.1.4.4 Other developments
- 15.2.1.4.5 MnM view
- 15.2.1.4.5.1 Key strengths
- 15.2.1.4.5.2 Strategic choices
- 15.2.1.4.5.3 Weaknesses & competitive threats
- 15.2.1.5 Evotec
- 15.2.1.5.1 Business overview
- 15.2.1.5.2 Services offered
- 15.2.1.5.2.1 Deals
- 15.2.1.5.3 MnM view
- 15.2.1.5.3.1 Key strengths
- 15.2.1.5.3.2 Strategic choices
- 15.2.1.5.3.3 Weaknesses & competitive threats
- 15.2.1.6 KLIFOVET GmbH
- 15.2.1.6.1 Business overview
- 15.2.1.6.2 Services offered
- 15.2.1.7 Clinglobal
- 15.2.1.7.1 Business overview
- 15.2.1.7.2 Services offered
- 15.2.1.7.3 Recent developments
- 15.2.1.7.3.1 Service launches
- 15.2.1.7.3.2 Deals
- 15.2.1.7.3.3 Other developments
- 15.2.1.8 BioAgile Therapeutics Private Limited
- 15.2.1.8.1 Business overview
- 15.2.1.8.2 Services offered
- 15.2.1.9 Vetspin SRL
- 15.2.1.9.1 Business overview
- 15.2.1.9.2 Services offered
- 15.2.1.10 Veterinary Research Management
- 15.2.1.10.1 Business overview
- 15.2.1.10.2 Services offered
- 15.2.1.1 Labcorp
- 15.2.2 OTHER PLAYERS
- 15.2.2.1 Ridgeway Research Ltd.
- 15.2.2.2 Lohlein and Wolf Vet Research
- 15.2.2.3 Cebiphar
- 15.2.2.4 OCRvet
- 15.2.2.5 East Tennessee Clinical Research, Inc.
- 15.2.1 KEY PLAYERS
16 RESEARCH METHODOLOGY
- 16.1 RESEARCH DATA
- 16.2 RESEARCH METHODOLOGY DESIGN
- 16.2.1 SECONDARY DATA
- 16.2.1.1 Key data from secondary sources
- 16.2.2 PRIMARY DATA
- 16.2.2.1 Key data from primary sources
- 16.2.2.2 Key industry insights
- 16.2.1 SECONDARY DATA
- 16.3 MARKET SIZE ESTIMATION
- 16.3.1 BOTTOM-UP APPROACH
- 16.4 MARKET BREAKDOWN & DATA TRIANGULATION
- 16.5 MARKET SHARE ESTIMATION
- 16.5.1 RESEARCH ASSUMPTIONS
- 16.5.2 GROWTH RATE ASSUMPTIONS
- 16.6 RISK ASSESSMENT
- 16.7 RESEARCH LIMITATIONS
- 16.7.1 METHODOLOGY-RELATED LIMITATIONS
- 16.7.2 SCOPE-RELATED LIMITATIONS
17 APPENDIX
- 17.1 DISCUSSION GUIDE
- 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 17.3 CUSTOMIZATION OPTIONS
- 17.3.1 SERVICE ANALYSIS
- 17.3.2 COMPANY INFORMATION
- 17.3.3 GEOGRAPHIC ANALYSIS
- 17.3.4 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS
- 17.3.5 COUNTRY-LEVEL VOLUME ANALYSIS, BY PRODUCT TYPE
- 17.3.6 MARKET SHARE ANALYSIS, BY SERVICE (TOP 5 PLAYERS)
- 17.3.7 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS
- 17.4 RELATED REPORTS
- 17.5 AUTHOR DETAILS
List of Tables
- TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD)
- TABLE 2 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: PORTER'S FIVE FORCES ANALYSIS
- TABLE 3 GDP CHANGE, BY KEY COUNTRY, 2021-2030 (IN USD BILLION)
- TABLE 4 AVERAGE SELLING PRICE TREND OF API & FILL-FINISH PHARMACEUTICALS & BIOLOGICS, BY KEY PLAYER, 2023-2025
- TABLE 5 AVERAGE SELLING PRICE TREND OF SMALL-MOLECULE PHARMACEUTICALS FOR API/DRUG SUBSTANCE MANUFACTURING, BY REGION, 2023-2025 (USD PER KG)
- TABLE 6 AVERAGE SELLING PRICE TREND OF SMALL-MOLECULE PHARMACEUTICALS FOR FILL-FINISH/DRUG PRODUCT MANUFACTURING, BY REGION, 2023-2025 (USD PER FINISHED UNIT)
- TABLE 7 AVERAGE SELLING PRICE TREND OF ANIMAL HEALTH BIOLOGICS & VACCINES FOR API/DRUG SUBSTANCE MANUFACTURING, BY REGION, 2023-2025 (USD PER KG)
- TABLE 8 AVERAGE SELLING PRICE TREND OF ANIMAL HEALTH BIOLOGICS & VACCINES FOR FILL-FINISH/DRUG PRODUCT MANUFACTURING, BY REGION, 2023-2025 (USD PER FINISHED UNIT)
- TABLE 9 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: MAJOR CONFERENCES & EVENTS IN 2026-2027
- TABLE 10 CASE STUDY 1: END-TO-END CDMO SUPPORT FOR ANIMAL HEALTH LATERAL FLOW DIAGNOSTICS
- TABLE 11 CASE STUDY 2: END-TO-END CDMO SUPPORT FOR FIRST-IN-CLASS VETERINARY MONOCLONAL ANTIBODY (MAB)
- TABLE 12 CASE STUDY 3: END-TO-END BIOLOGICS OPTIMIZATION FOR CANINE ANTIBODY PROGRAMS
- TABLE 13 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: MAJOR PATENTS
- TABLE 14 KEY COMPANIES IMPLEMENTING AI IN VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET
- TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 17 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY CDMOS & CROS
- TABLE 19 KEY BUYING CRITERIA FOR TOP THREE END USERS
- TABLE 20 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 21 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 22 KEY PLAYERS PROVIDING CRO SERVICES
- TABLE 23 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 24 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 25 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR DISCOVERY & PRE-CLINICAL STUDIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 26 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR VETERINARY CLINICAL TRIALS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 27 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANALYTICAL & BIOANALYTICAL SERVICES AND QUALITY ASSURANCE, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 28 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR REGULATORY AFFAIRS & CONSULTING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 29 KEY PLAYERS PROVIDING CDMO SERVICES
- TABLE 30 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 31 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 32 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR PROCESS API & FORMULATION DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 33 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MANUFACTURING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 34 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR PACKAGING & LABELING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 35 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR QUALITY/STABILITY & POST-MARKET SUPPORT, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 36 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 37 KEY PLAYERS PROVIDING VETERINARY MEDICINES
- TABLE 38 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 39 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 40 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 41 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 42 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS IN API/DRUG SUBSTANCE MANUFACTURING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 43 SMALL-MOLECULE PHARMACEUTICALS MARKET FOR API/DRUG SUBSTANCE MANUFACTURING, BY TYPE, 2024-2031 (METRIC TONS)
- TABLE 44 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS IN FILL-FINISH/DRUG PRODUCT MANUFACTURING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 45 SMALL-MOLECULE PHARMACEUTICALS MARKET FOR FILL-FINISH/DRUG PRODUCT MANUFACTURING, BY TYPE, 2024-2031 (TEN THOUSAND UNITS)
- TABLE 46 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 47 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 48 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES IN API/DRUG SUBSTANCE MANUFACTURING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 49 ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR API/DRUG SUBSTANCE MANUFACTURING, BY TYPE, 2024-2031 (METRIC TONS)
- TABLE 50 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES IN FILL-FINISH/DRUG PRODUCT MANUFACTURING, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 51 ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR FILL-FINISH/DRUG PRODUCT MANUFACTURING, BY TYPE, 2024-2031 (THOUSAND UNITS)
- TABLE 52 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICATED FEED & SUPPLEMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 53 KEY PLAYERS PROVIDING VETERINARY MEDICAL DEVICES
- TABLE 54 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 55 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 56 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR DIAGNOSTICS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 57 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MONITORING SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 58 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR IMPLANTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 59 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 60 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 61 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 62 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR DOGS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 63 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CATS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 64 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR HORSES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 65 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 66 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 67 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 68 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CATTLE, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 69 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SWINE, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 70 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR POULTRY, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 71 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SHEEP & GOATS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 72 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR OTHER LIVESTOCK ANIMALS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 73 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 74 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MULTINATIONAL ANIMAL HEALTH COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 75 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MID-SIZED/SPECIALTY ANIMAL HEALTH FIRMS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 76 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR START-UPS & VETERINARY BIOTECH FIRMS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 77 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 78 NORTH AMERICA: SMALL-MOLECULE PHARMACEUTICALS MARKET FOR API/DRUG SUBSTANCES, BY TYPE, 2024-2031 (METRIC TONS)
- TABLE 79 NORTH AMERICA: SMALL-MOLECULE PHARMACEUTICALS MARKET FOR FILL-FINISH/DRUG PRODUCTS, BY TYPE, 2024-2031 (TEN THOUSAND UNITS)
- TABLE 80 NORTH AMERICA: ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR API/DRUG SUBSTANCES, BY TYPE, 2024-2031 (METRIC TONS)
- TABLE 81 NORTH AMERICA: ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR FILL-FINISH/DRUG PRODUCTS, BY TYPE, 2024-2031 (THOUSAND UNITS)
- TABLE 82 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 83 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 84 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 85 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 86 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 87 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 88 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 89 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 90 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 91 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 92 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 93 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 94 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 95 US: KEY MACROINDICATORS
- TABLE 96 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 97 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 98 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 99 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 100 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 101 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 102 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 103 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 104 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 105 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 106 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 107 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 108 CANADA: KEY MACROINDICATORS
- TABLE 109 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 110 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 111 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 112 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 113 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 114 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 115 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 116 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 117 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 118 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 119 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 120 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 121 EUROPE: SMALL-MOLECULE PHARMACEUTICALS MARKET FOR API/DRUG SUBSTANCES, BY TYPE, 2024-2031 (METRIC TONS)
- TABLE 122 EUROPE: SMALL-MOLECULE PHARMACEUTICALS MARKET FOR FILL-FINISH/DRUG PRODUCTS, BY TYPE, 2024-2031 (TEN THOUSAND UNITS)
- TABLE 123 EUROPE: ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR API/DRUG SUBSTANCES, BY TYPE, 2024-2031 (METRIC TONS)
- TABLE 124 EUROPE: ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR FILL-FINISH/DRUG PRODUCTS, BY TYPE, 2024-2031 (THOUSAND UNITS)
- TABLE 125 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 126 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 127 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 128 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 129 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 130 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 131 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 132 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 133 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 134 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 135 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 136 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 137 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 138 GERMANY: KEY MACROINDICATORS
- TABLE 139 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 140 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 141 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 142 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 143 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 144 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 145 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 146 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 147 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 148 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 149 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 150 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 151 UK: KEY MACROINDICATORS
- TABLE 152 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 153 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 154 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 155 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 156 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 157 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 158 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 159 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 160 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 161 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 162 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 163 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 164 FRANCE: KEY MACROINDICATORS
- TABLE 165 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 166 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 167 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 168 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 169 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 170 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 171 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 172 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 173 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 174 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 175 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 176 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 177 ITALY: KEY MACROINDICATORS
- TABLE 178 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 179 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 180 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 181 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 182 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 183 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 184 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 185 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 186 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 187 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 188 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 189 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 190 SPAIN: KEY MACROINDICATORS
- TABLE 191 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 192 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 193 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 194 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 195 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 196 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 197 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 198 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 199 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 200 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 201 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 202 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 203 NETHERLANDS: KEY MACROINDICATORS
- TABLE 204 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 205 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 206 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 207 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 208 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 209 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 210 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 211 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 212 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 213 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 214 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 215 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 216 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 217 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 218 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 219 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 220 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 221 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 222 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 223 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 224 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 225 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 226 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 227 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 228 ASIA PACIFIC: SMALL-MOLECULE PHARMACEUTICALS MARKET FOR API/DRUG SUBSTANCES, BY TYPE, 2024-2031 (METRIC TONS)
- TABLE 229 ASIA PACIFIC: SMALL-MOLECULE PHARMACEUTICALS MARKET FOR FILL-FINISH/DRUG PRODUCTS, BY TYPE, 2024-2031 (TEN THOUSAND UNITS)
- TABLE 230 ASIA PACIFIC: ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR API/DRUG SUBSTANCES, BY TYPE, 2024-2031 (METRIC TONS)
- TABLE 231 ASIA PACIFIC: ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR FILL-FINISH/DRUG PRODUCTS, BY TYPE, 2024-2031 (THOUSAND UNITS)
- TABLE 232 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 233 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 234 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 235 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 236 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 237 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 238 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 239 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 240 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 241 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 242 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 243 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 244 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 245 CHINA: KEY MACROINDICATORS
- TABLE 246 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 247 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 248 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 249 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 250 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 251 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 252 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 253 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 254 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 255 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 256 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 257 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 258 JAPAN: KEY MACROINDICATORS
- TABLE 259 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 260 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 261 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 262 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 263 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 264 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 265 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 266 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 267 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 268 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 269 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 270 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 271 INDIA: KEY MACROINDICATORS
- TABLE 272 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 273 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 274 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 275 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 276 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 277 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 278 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 279 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 280 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 281 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 282 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 283 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 284 AUSTRALIA: KEY MACROINDICATORS
- TABLE 285 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 286 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 287 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 288 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 289 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 290 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 291 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 292 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 293 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 294 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 295 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 296 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 297 SOUTH KOREA: KEY MACROINDICATORS
- TABLE 298 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 299 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 300 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 301 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 302 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 303 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 304 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 305 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 306 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 307 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 308 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 309 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 310 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 311 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 312 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 313 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 314 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 315 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 316 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 317 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 318 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 319 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 320 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 321 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 322 NEW ZEALAND: KEY MACROINDICATORS
- TABLE 323 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 324 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 325 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 326 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 327 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 328 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 329 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 330 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 331 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 332 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 333 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 334 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 335 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 336 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 337 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 338 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 339 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 340 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 341 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 342 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 343 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 344 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 345 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 346 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 347 LATIN AMERICA: SMALL-MOLECULE PHARMACEUTICALS MARKET FOR API/DRUG SUBSTANCES, BY TYPE, 2024-2031 (METRIC TONS)
- TABLE 348 LATIN AMERICA: SMALL-MOLECULE PHARMACEUTICALS MARKET FOR FILL-FINISH/DRUG PRODUCTS, BY TYPE, 2024-2031 (TEN THOUSAND UNITS)
- TABLE 349 LATIN AMERICA: ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR API/DRUG SUBSTANCES, BY TYPE, 2024-2031 (METRIC TONS)
- TABLE 350 LATIN AMERICA: ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR FILL-FINISH/DRUG PRODUCTS, BY TYPE, 2024-2031 (THOUSAND UNITS)
- TABLE 351 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 352 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 353 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 354 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 355 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 356 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 357 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 358 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 359 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 360 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 361 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 362 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 363 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 364 BRAZIL: KEY MACROINDICATORS
- TABLE 365 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 366 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 367 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 368 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 369 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 370 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 371 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 372 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 373 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 374 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 375 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 376 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 377 MEXICO: KEY MACROINDICATORS
- TABLE 378 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 379 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 380 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 381 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 382 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 383 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 384 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 385 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 386 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 387 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 388 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 389 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 390 ARGENTINA: KEY MACROINDICATORS
- TABLE 391 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 392 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 393 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 394 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 395 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 396 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 397 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 398 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 399 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 400 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 401 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 402 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 403 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 404 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 405 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 406 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 407 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 408 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 409 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 410 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 411 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 412 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 413 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 414 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 415 MIDDLE EAST & AFRICA: SMALL-MOLECULE PHARMACEUTICALS MARKET FOR API/DRUG SUBSTANCES, BY TYPE, 2024-2031 (METRIC TONS)
- TABLE 416 MIDDLE EAST & AFRICA: SMALL-MOLECULE PHARMACEUTICALS MARKET FOR FILL-FINISH/DRUG PRODUCTS, BY TYPE, 2024-2031 (TEN THOUSAND UNITS)
- TABLE 417 MIDDLE EAST & AFRICA: ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR API/DRUG SUBSTANCES, BY TYPE, 2024-2031 (METRIC TONS)
- TABLE 418 MIDDLE EAST & AFRICA: ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR FILL-FINISH/DRUG PRODUCTS, BY TYPE, 2024-2031 (THOUSAND UNITS)
- TABLE 419 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 420 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 421 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 422 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 423 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 424 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 425 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 426 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 427 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 428 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 429 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 430 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 431 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 432 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 433 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 434 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 435 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 436 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 437 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 438 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 439 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 440 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 441 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 442 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 443 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 444 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 445 KINGDOM OF SAUDI ARABIA: KEY MACROINDICATORS
- TABLE 446 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 447 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 448 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 449 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 450 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 451 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 452 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 453 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 454 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 455 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 456 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 457 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 458 UNITED ARAB EMIRATES: KEY MACROINDICATORS
- TABLE 459 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 460 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 461 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 462 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 463 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 464 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 465 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 466 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 467 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 468 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 469 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 470 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 471 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 472 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 473 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 474 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 475 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 476 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 477 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 478 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 479 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 480 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 481 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 482 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 483 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024-2031 (USD MILLION)
- TABLE 484 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 485 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 486 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 487 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 488 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 489 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 490 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 491 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 492 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 493 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 494 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 495 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET
- TABLE 496 VETERINARY CONTRACT RESEARCH ORGANIZATIONS MARKET: DEGREE OF COMPETITION
- TABLE 497 VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS MARKET: DEGREE OF COMPETITION
- TABLE 498 VETERINARY CRO MARKET: REGION FOOTPRINT
- TABLE 499 VETERINARY CRO MARKET: SERVICE FOOTPRINT
- TABLE 500 VETERINARY CRO MARKET: PRODUCT TYPE FOOTPRINT
- TABLE 501 VETERINARY CRO MARKET: ANIMAL TYPE FOOTPRINT
- TABLE 502 VETERINARY CRO MARKET: DETAILED LIST OF KEY VETERINARY CRO STARTUPS/SMES
- TABLE 503 VETERINARY CRO MARKET: COMPETITIVE BENCHMARKING OF KEY VETERINARY CRO STARTUPS/SMES
- TABLE 504 VETERINARY CDMO MARKET: REGION FOOTPRINT
- TABLE 505 VETERINARY CDMO MARKET: SERVICE FOOTPRINT
- TABLE 506 VETERINARY CDMO MARKET: PRODUCT TYPE FOOTPRINT
- TABLE 507 VETERINARY CDMO MARKET: ANIMAL TYPE FOOTPRINT
- TABLE 508 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: DETAILED LIST OF KEY VETERINARY CDMO STARTUPS/SMES
- TABLE 509 VETERINARY CDMO MARKET: COMPETITIVE BENCHMARKING OF KEY VETERINARY CDMO STARTUPS/SMES
- TABLE 510 VETERINARY CDMO & CRO MARKET: SERVICE LAUNCHES & APPROVALS, JANUARY 2022-NOVEMBER 2025
- TABLE 511 VETERINARY CDMO & CRO MARKET: DEALS, JANUARY 2022-NOVEMBER 2025
- TABLE 512 VETERINARY CDMO & CRO MARKET: EXPANSIONS, JANUARY 2022-NOVEMBER 2025
- TABLE 513 VETERINARY CDMO & CRO MARKET: OTHER DEVELOPMENTS, JANUARY 2022-NOVEMBER 2025
- TABLE 514 ARGENTA HOLDCO LIMITED: COMPANY OVERVIEW
- TABLE 515 ARGENTA HOLDCO LIMITED: SERVICES OFFERED
- TABLE 516 ARGENTA HOLDCO LIMITED: SERVICE LAUNCHES & UPGRADES, JANUARY 2022-NOVEMBER 2025
- TABLE 517 ARGENTA HOLDCO LIMITED: DEALS, JANUARY 2022-NOVEMBER 2025
- TABLE 518 ARGENTA HOLDCO LIMITED: EXPANSIONS, JANUARY 2022-NOVEMBER 2025
- TABLE 519 AENOVA GROUP: COMPANY OVERVIEW
- TABLE 520 AENOVA GROUP: SERVICES OFFERED
- TABLE 521 AENOVA GROUP: EXPANSIONS, JANUARY 2022-NOVEMBER 2025
- TABLE 522 AENOVA GROUP: OTHER DEVELOPMENTS, JANUARY 2022-NOVEMBER 2025
- TABLE 523 FAREVA SA: COMPANY OVERVIEW
- TABLE 524 FAREVA SA: SERVICES OFFERED
- TABLE 525 VETIO: COMPANY OVERVIEW
- TABLE 526 VETIO: SERVICES OFFERED
- TABLE 527 TRIRX PHARMACEUTICAL SERVICES: COMPANY OVERVIEW
- TABLE 528 TRIRX PHARMACEUTICAL SERVICES: SERVICES OFFERED
- TABLE 529 INDIAN IMMUNOLOGICALS LTD.: COMPANY OVERVIEW
- TABLE 530 INDIAN IMMUNOLOGICALS LTD.: SERVICES OFFERED
- TABLE 531 RECIPHARM AB: COMPANY OVERVIEW
- TABLE 532 RECIPHARM AB: SERVICES OFFERED
- TABLE 533 RECIPHARM AB: TECHNOLOGY LAUNCHES, JANUARY 2022-NOVEMBER 2025
- TABLE 534 RECIPHARM AB: DEALS, JANUARY 2022-NOVEMBER 2025
- TABLE 535 RECIPHARM AB: EXPANSIONS, JANUARY 2022-NOVEMBER 2025
- TABLE 536 RECIPHARM AB: OTHER DEVELOPMENTS, JANUARY 2022-NOVEMBER 2025
- TABLE 537 LABIANA: COMPANY OVERVIEW
- TABLE 538 LABIANA: SERVICES OFFERED
- TABLE 539 LABIANA: OTHER DEVELOPMENTS, JANUARY 2022-NOVEMBER 2025
- TABLE 540 SYNGENE INTERNATIONAL LIMITED: COMPANY OVERVIEW
- TABLE 541 SYNGENE INTERNATIONAL LIMITED: SERVICES OFFERED
- TABLE 542 SYNGENE INTERNATIONAL LIMITED: DEALS, JANUARY 2022-NOVEMBER 2025
- TABLE 543 SYNGENE INTERNATIONAL LIMITED: OTHER DEVELOPMENTS, JANUARY 2022-NOVEMBER 2025
- TABLE 544 CZ VACCINES: COMPANY OVERVIEW
- TABLE 545 CZ VACCINES: SERVICES OFFERED
- TABLE 546 AB7 GROUP: COMPANY OVERVIEW
- TABLE 547 KELA HEALTH: COMPANY OVERVIEW
- TABLE 548 EIRGEN PHARMA: COMPANY OVERVIEW
- TABLE 549 BIOINGENIUM: COMPANY OVERVIEW
- TABLE 550 ELISE BIOPHARMA: COMPANY OVERVIEW
- TABLE 551 LABCORP: COMPANY OVERVIEW
- TABLE 552 LABCORP: SERVICES OFFERED
- TABLE 553 LABCORP: TECHNOLOGY LAUNCHES, JANUARY 2022-NOVEMBER 2025
- TABLE 554 LABCORP: EXPANSIONS, JANUARY 2022-NOVEMBER 2025
- TABLE 555 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
- TABLE 556 EUROFINS SCIENTIFIC: SERVICES OFFERED
- TABLE 557 EUROFINS SCIENTIFIC: DEALS, JANUARY 2022-NOVEMBER 2025
- TABLE 558 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
- TABLE 559 CHARLES RIVER LABORATORIES: SERVICES OFFERED
- TABLE 560 KNOELL GERMANY GMBH: COMPANY OVERVIEW
- TABLE 561 KNOELL GERMANY GMBH: SERVICES OFFERED
- TABLE 562 KNOELL GERMANY GMBH: DEALS, JANUARY 2022-NOVEMBER 2025
- TABLE 563 KNOELL GERMANY GMBH: OTHER DEVELOPMENTS, JANUARY 2022-NOVEMBER 2025
- TABLE 564 EVOTEC: COMPANY OVERVIEW
- TABLE 565 EVOTEC: SERVICES OFFERED
- TABLE 566 EVOTEC: DEALS, JANUARY 2022-NOVEMBER 2025
- TABLE 567 KLIFOVET GMBH: COMPANY OVERVIEW
- TABLE 568 KLIFOVET GMBH: SERVICES OFFERED
- TABLE 569 CLINGLOBAL: COMPANY OVERVIEW
- TABLE 570 CLINGLOBAL: SERVICES OFFERED
- TABLE 571 CLINGLOBAL: SERVICE LAUNCHES, JANUARY 2022-NOVEMBER 2025
- TABLE 572 CLINGLOBAL: DEALS, JANUARY 2022-NOVEMBER 2025
- TABLE 573 CLINGLOBAL: OTHER DEVELOPMENTS, JANUARY 2022-NOVEMBER 2025
- TABLE 574 BIOAGILE THERAPEUTICS PRIVATE LIMITED: COMPANY OVERVIEW
- TABLE 575 BIOAGILE THERAPEUTICS PRIVATE LIMITED: SERVICES OFFERED
- TABLE 576 VETSPIN SRL: COMPANY OVERVIEW
- TABLE 577 VETSPIN SRL: SERVICES OFFERED
- TABLE 578 VETERINARY RESEARCH MANAGEMENT: COMPANY OVERVIEW
- TABLE 579 VETERINARY RESEARCH MANAGEMENT: SERVICES OFFERED
- TABLE 580 RIDGEWAY RESEARCH LTD.: COMPANY OVERVIEW
- TABLE 581 LOHLEIN AND WOLF VET RESEARCH: COMPANY OVERVIEW
- TABLE 582 CEBIPHAR: COMPANY OVERVIEW
- TABLE 583 OCRVET: COMPANY OVERVIEW
- TABLE 584 EAST TENNESSEE CLINICAL RESEARCH, INC.: COMPANY OVERVIEW
- TABLE 585 RISK ASSESSMENT ANALYSIS
List of Figures
- FIGURE 1 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET SEGMENTATION & REGIONAL SCOPE
- FIGURE 2 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2026 VS. 2031 (USD MILLION)
- FIGURE 3 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2026 VS. 2031 (USD MILLION)
- FIGURE 4 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2026 VS. 2031 (USD MILLION)
- FIGURE 5 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2026 VS. 2031 (USD MILLION)
- FIGURE 6 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2026 VS. 2031 (USD MILLION)
- FIGURE 7 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2026 VS. 2031 (USD MILLION)
- FIGURE 8 GEOGRAPHIC SNAPSHOT OF VETERINARY CROS MARKET
- FIGURE 9 GEOGRAPHIC SNAPSHOT OF VETERINARY CDMOS MARKET
- FIGURE 10 ADVANCEMENTS IN VETERINARY BIOLOGICS TO FUEL MARKET GROWTH
- FIGURE 11 CDMO SERVICES SEGMENT IN CHINA ACCOUNTED FOR LARGEST MARKET SHARE IN 2024
- FIGURE 12 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
- FIGURE 13 ASIA PACIFIC TO RECORD HIGHEST CAGR DURING FORECAST PERIOD
- FIGURE 14 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
- FIGURE 15 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
- FIGURE 16 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
- FIGURE 17 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: PORTER'S FIVE FORCES ANALYSIS
- FIGURE 18 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: SUPPLY CHAIN ANALYSIS
- FIGURE 19 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: VALUE CHAIN ANALYSIS
- FIGURE 20 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: ECOSYSTEM ANALYSIS
- FIGURE 21 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- FIGURE 22 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: INVESTMENT & FUNDING SCENARIO
- FIGURE 23 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2014-NOVEMBER 2025)
- FIGURE 24 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY PHARMACEUTICAL PATENTS (JANUARY 2014-NOVEMBER 2025)
- FIGURE 25 AI USE CASES
- FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY CDMOS & CROS
- FIGURE 27 KEY BUYING CRITERIA FOR TOP THREE END USERS
- FIGURE 28 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: GEOGRAPHIC SNAPSHOT
- FIGURE 29 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET SNAPSHOT
- FIGURE 30 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET SNAPSHOT
- FIGURE 31 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY CROS MARKET, 2021-2025
- FIGURE 32 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY CDMOS MARKET, 2021-2025
- FIGURE 33 GLOBAL MARKET SHARE ANALYSIS OF VETERINARY CONTRACT RESEARCH ORGANIZATIONS, 2025
- FIGURE 34 RANKING OF VETERINARY CONTRACT RESEARCH ORGANIZATIONS, 2025
- FIGURE 35 US MARKET SHARE ANALYSIS OF VETERINARY CONTRACT RESEARCH ORGANIZATIONS (2025)
- FIGURE 36 EUROPE MARKET SHARE ANALYSIS OF VETERINARY CONTRACT RESEARCH ORGANIZATIONS (2025)
- FIGURE 37 GLOBAL MARKET SHARE ANALYSIS OF VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, 2025
- FIGURE 38 RANKING OF VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, 2025
- FIGURE 39 US MARKET SHARE ANALYSIS OF VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS (2025)
- FIGURE 40 EUROPE MARKET SHARE ANALYSIS OF VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS (2025)
- FIGURE 41 VETERINARY CRO MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
- FIGURE 42 VETERINARY CRO MARKET: COMPANY FOOTPRINT
- FIGURE 43 VETERINARY CRO MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
- FIGURE 44 VETERINARY CDMO MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
- FIGURE 45 VETERINARY CONTRACT CDMO MARKET: COMPANY FOOTPRINT
- FIGURE 46 VETERINARY CDMO MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
- FIGURE 47 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: SERVICE COMPARATIVE ANALYSIS
- FIGURE 48 EV/EBITDA OF KEY VENDORS
- FIGURE 49 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
- FIGURE 50 AENOVA GROUP: COMPANY SNAPSHOT (2024)
- FIGURE 51 LABIANA: COMPANY SNAPSHOT (2024)
- FIGURE 52 SYNGENE INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2025)
- FIGURE 53 LABCORP: COMPANY SNAPSHOT (2024)
- FIGURE 54 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2024)
- FIGURE 55 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2024)
- FIGURE 56 EVOTEC: COMPANY SNAPSHOT (2024)
- FIGURE 57 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: RESEARCH DESIGN
- FIGURE 58 PRIMARY SOURCES
- FIGURE 59 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (SUPPLY SIDE)
- FIGURE 60 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION (DEMAND SIDE)
- FIGURE 61 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
- FIGURE 62 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
- FIGURE 63 REVENUE SHARE ANALYSIS ILLUSTRATION: CHARLES RIVER LABORATORIES
- FIGURE 64 REVENUE ANALYSIS OF TOP FIVE COMPANIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET (2025)
- FIGURE 65 DEMAND-SIDE MARKET ESTIMATION FOR VETERINARY CRO SERVICES
- FIGURE 66 DEMAND-SIDE MARKET ESTIMATION FOR VETERINARY CDMO SERVICES
- FIGURE 67 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET (2026-2031)
- FIGURE 68 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
- FIGURE 69 TOP-DOWN APPROACH
- FIGURE 70 BOTTOM-UP APPROACH
- FIGURE 71 MARKET DATA TRIANGULATION METHODOLOGY
02-2729-4219
+886-2-2729-4219
澳洲醫療設備契約製造市場－按應用、治療領域和器材類別分類：產業趨勢和全球預測（至2035年）
2026年全球醫療設備契約製造市場報告
體外診斷（IVD）契約製造市場分析及至2035年預測：按類型、產品、服務、技術、組件、應用、最終用戶、流程和設備分類
體外診斷契約製造市場－全球產業規模、佔有率、趨勢、機會及預測（依設備類型、技術、服務類型、地區及競爭格局分類，2021-2031年）
全球體外診斷（IVD）合約製造市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考量因素以及未來預測（2026-2034）
醫療設備契約製造市場規模、佔有率和成長分析（按產品類別、服務類型、治療領域、最終用戶和地區分類）－2026-2033年產業預測
體外診斷設備契約製造市場規模、佔有率和成長分析（按產品類型、技術、服務類型和地區分類）－2026年至2033年產業預測
體外診斷（IVD）契約製造市場預測至2032年：按服務類型、產品類型、技術、合約類型、產能、最終用戶和地區分類的全球分析
診斷設備CDMO市場規模、佔有率和趨勢分析報告：按服務、類別、應用、最終用途、地區和細分市場預測（2025-2033年）
醫療設備契約製造：全球市場
▼